This medical technology company develops animal-free preclinical drug testing platforms using tissue engineering, 3D bioprinting, AI, and biomicrofluidics. Their technology enables pharmaceutical companies to perform precise preclinical testing of drugs, formulations, materials, and devices.
Funding
Funding not disclosed
Founders
Product
Problem
Traditional preclinical drug testing relies heavily on animal models, which are costly, time-consuming, and often fail to accurately predict drug efficacy or toxicity in humans. The reliance on animal testing raises ethical concerns and contributes to the high failure rate of drugs in clinical trials, resulting in significant financial losses for pharmaceutical companies.
Solution
Cellverse offers animal-free preclinical drug testing platforms that utilize tissue engineering, 3D bioprinting, AI, and biomicrofluidics to create in vitro physiological and pathological models. These models provide a more accurate and ethical alternative for preclinical trials, enabling pharmaceutical companies to assess the efficacy and safety of drugs, formulations, materials, and devices with greater precision. By mimicking human physiology, Cellverse's technology aims to reduce the reliance on animal testing, lower drug development costs, and improve the success rate of clinical trials. The company also develops bioinks and other auxiliary technologies tailored to specific research requirements.
Target Audience
Cellverse's primary customers are pharmaceutical companies and biomedical research groups seeking animal-free, predictive preclinical testing platforms for drug development and precision medicine.
Features
- 3D bioprinted tissue models that mimic human physiology and disease states
- Microfluidic devices for precise control of the cellular microenvironment
- AI-powered data analysis for predictive modeling of drug responses
- Customizable bioinks for creating specific tissue types
- In vitro pathological models for studying disease mechanisms
- Non-animal testing methods that align with ethical considerations